IDO Inhibitor Study for Relapsed or Refractory Solid Tumors - No Study Results Posted

IDO Inhibitor Study for Relapsed or Refractory Solid Tumors (D-1MT)

This study is currently recruiting participants.

Study NCT00739609 Information provided by NewLink Genetics Corporation

First Received: August 20, 2008 Last Updated: December 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2012
Estimated Primary Completion Date:	June 2012 (Final data collection date for primary outcome measure)

No publications provided by NewLink Genetics Corporation

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ino K. Indoleamine 2,3-dioxygenase and immune tolerance in ovarian cancer. Curr Opin Obstet Gynecol. 2011 Feb;23(1):13-8.